| Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors Y Oji, T Suzuki, Y Nakano, M Maruno, S Nakatsuka, T Jomgeow, S Abeno, ... Cancer science 95 (10), 822-827, 2004 | 152 | 2004 |
| AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1 S Nishida, N Hosen, T Shirakata, K Kanato, M Yanagihara, S Nakatsuka, ... Blood 107 (8), 3303-3312, 2006 | 151 | 2006 |
| Antiapoptotic function of 17AA (+) WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway K Ito, Y Oji, N Tatsumi, S Shimizu, Y Kanai, T Nakazawa, M Asada, ... Oncogene 25 (30), 4217-4229, 2006 | 133 | 2006 |
| Novel human NK cell line carrying CAR targeting EGFRvIII induces antitumor effects in glioblastoma cells T Murakami, T Nakazawa, A Natsume, F Nishimura, M Nakamura, ... Anticancer research 38 (9), 5049-5056, 2018 | 98 | 2018 |
| Wilms’ tumor gene WT1 17AA(–)/KTS(–) isoform induces morphological changes and promotes cell migration and invasion in vitro T Jomgeow, Y Oji, N Tsuji, Y Ikeda, K Ito, A Tsuda, T Nakazawa, ... Cancer science 97 (4), 259-270, 2006 | 98 | 2006 |
| Effect of CRISPR/Cas9-mediated PD-1-disrupted primary human third-generation CAR-T cells targeting EGFRvIII on in vitro human glioblastoma cell growth T Nakazawa, A Natsume, F Nishimura, T Morimoto, R Matsuda, ... Cells 9 (4), 998, 2020 | 84 | 2020 |
| Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro Y Tanaka, T Nakazawa, M Nakamura, F Nishimura, R Matsuda, K Omoto, ... PLoS One 14 (3), e0212455, 2019 | 40 | 2019 |
| CRISPR-Cas9–Mediated TIM3 Knockout in Human Natural Killer Cells Enhances Growth Inhibitory Effects on Human Glioma Cells T Morimoto, T Nakazawa, R Matsuda, F Nishimura, M Nakamura, ... International Journal of Molecular Sciences 22 (7), 3489, 2021 | 39 | 2021 |
| Cytotoxic human peripheral blood-derived γδT cells kill glioblastoma cell lines: implications for cell-based immunotherapy for patients with glioblastoma T Nakazawa, M Nakamura, YS Park, Y Motoyama, Y Hironaka, ... Journal of neuro-oncology 116, 31-39, 2014 | 33 | 2014 |
| Antitumor effects of minodronate, a third-generation nitrogen-containing bisphosphonate, in synergy with γδT cells in human glioblastoma in vitro and in vivo T Nakazawa, M Nakamura, R Matsuda, F Nishimura, YS Park, ... Journal of neuro-oncology 129, 231-241, 2016 | 21 | 2016 |
| The Wilms’ tumor gene WT1 is a common marker of progenitor cells in fetal liver K Kanato, N Hosen, M Yanagihara, N Nakagata, T Shirakata, T Nakazawa, ... Biochemical and biophysical research communications 326 (4), 836-843, 2005 | 19 | 2005 |
| KHYG-1 cells with EGFRvIII-specific CAR induced a pseudoprogression-like feature in subcutaneous tumours derived from glioblastoma-like cells T Nakazawa, T Murakami, A Natsume, F Nishimura, T Morimoto, ... Anticancer Research 40 (6), 3231-3237, 2020 | 16 | 2020 |
| Evaluation of Comprehensive Gene Expression and NK Cell-Mediated Killing in Glioblastoma Cell Line-Derived Spheroids T Morimoto, T Nakazawa, R Matsuda, F Nishimura, M Nakamura, S Yamada, I ... Cancers 13 (19), 4896, 2021 | 15 | 2021 |
| Expression of peptide transporter 1 has a positive correlation in protoporphyrin IX accumulation induced by 5-aminolevulinic acid with photodynamic detection of non-small cell … K Omoto, R Matsuda, Y Nakai, Y Tatsumi, T Nakazawa, Y Tanaka, ... Photodiagnosis and Photodynamic Therapy 25, 309-316, 2019 | 15 | 2019 |
| Establishment of an efficient ex vivo expansion strategy for human natural killer cells stimulated by defined cytokine cocktail and antibodies against natural killer cell … T Nakazawa, T Morimoto, R Maeoka, R Matsuda, M Nakamura, ... Regenerative Therapy 21, 185-191, 2022 | 13 | 2022 |
| Risk of brain herniation after craniotomy with lumbar spinal drainage: a propensity score analysis Y Motoyama, T Nakajima, Y Takamura, T Nakazawa, D Wajima, ... Journal of Neurosurgery 130 (5), 1710-1720, 2018 | 13 | 2018 |
| Natural Killer Cell-Based Immunotherapy against Glioblastoma T Morimoto, T Nakazawa, R Maeoka, I Nakagawa, T Tsujimura, R Matsuda International Journal of Molecular Sciences 24 (3), 2111, 2023 | 12 | 2023 |
| Ex Vivo Expanded and Activated Natural Killer Cells Prolong the Overall Survival of Mice with Glioblastoma-like Cell-Derived Tumors Y Shida, T Nakazawa, R Matsuda, T Morimoto, F Nishimura, M Nakamura, R ... International Journal of Molecular Sciences 22 (18), 9975, 2021 | 12 | 2021 |
| Identification of a gene element essential for leukemia-specific expression of transgenes N Hosen, M Yanagihara, T Nakazawa, K Kanato, S Nishida, T Shirakata, ... Leukemia 18, 415-419, 2004 | 12 | 2004 |
| Tumor-inhibition effect of levetiracetam in combination with temozolomide in glioblastoma cells A Marutani, M Nakamura, F Nishimura, T Nakazawa, R Matsuda, ... Neurochemical Journal 11, 43-49, 2017 | 10 | 2017 |
